The global bionic devices market is projected to grow from $7.17 billion in 2025 to $14.9 billion by 2034, representing a compound annual growth rate of 8.47% from 2026 to 2034. The report added to ResearchAndMarkets.com's offering attributes expansion to demand linked to organ failure, limb loss, sensory impairment, neurological disorders, aging populations, healthcare spending and rehabilitation investment. Artificial intelligence, machine learning, biosignal processing, neural interfaces and robotics are improving bionic limbs, cochlear and retinal implants, exoskeletons and other devices. Government support, reimbursement, research funding and military and veterans' healthcare programs are supporting commercialization, although costs, limited insurance coverage, infrastructure gaps, technical constraints and differing regulatory standards remain barriers. The market analysis covers products, fixation, technology, end users, countries and 10 named companies, with the United States, Germany, China and Saudi Arabia highlighted in the regional outlook.